- Home
- DAWN vs KRO Comparison
DAWN vs KRO Comparison
Compare DAWN & KRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DAWN
- KRO
- Stock Information
- Founded
- DAWN 2018
- KRO 1916
- Country
- DAWN United States
- KRO United States
- Employees
- DAWN N/A
- KRO N/A
- Industry
- DAWN Biotechnology: Pharmaceutical Preparations
- KRO Major Chemicals
- Sector
- DAWN Health Care
- KRO Industrials
- Exchange
- DAWN Nasdaq
- KRO Nasdaq
- Market Cap
- DAWN 624.8M
- KRO 503.9M
- IPO Year
- DAWN 2021
- KRO N/A
- Fundamental
- Price
- DAWN $9.39
- KRO $5.11
- Analyst Decision
- DAWN Strong Buy
- KRO Strong Sell
- Analyst Count
- DAWN 9
- KRO 2
- Target Price
- DAWN $26.56
- KRO $6.50
- AVG Volume (30 Days)
- DAWN 3.4M
- KRO 333.5K
- Earning Date
- DAWN 11-04-2025
- KRO 11-06-2025
- Dividend Yield
- DAWN N/A
- KRO 3.92%
- EPS Growth
- DAWN N/A
- KRO N/A
- EPS
- DAWN N/A
- KRO N/A
- Revenue
- DAWN $133,672,000.00
- KRO $1,864,200,000.00
- Revenue This Year
- DAWN $12.88
- KRO N/A
- Revenue Next Year
- DAWN $48.27
- KRO $6.29
- P/E Ratio
- DAWN N/A
- KRO N/A
- Revenue Growth
- DAWN 31.11
- KRO 0.01
- 52 Week Low
- DAWN $5.64
- KRO $4.08
- 52 Week High
- DAWN $14.46
- KRO $11.70
- Technical
- Relative Strength Index (RSI)
- DAWN 60.96
- KRO 58.28
- Support Level
- DAWN $8.16
- KRO $4.29
- Resistance Level
- DAWN $9.77
- KRO $4.94
- Average True Range (ATR)
- DAWN 0.70
- KRO 0.24
- MACD
- DAWN -0.02
- KRO 0.07
- Stochastic Oscillator
- DAWN 45.44
- KRO 97.12
About DAWN Day One Biopharmaceuticals Inc.
Day One Biopharmaceuticals Inc is a clinical-stage biopharmaceutical company. It is dedicated towards developing and commercializing targeted therapies for patients of all ages with genetically defined cancers. Initially, it focuses on clinical development efforts on pediatric patients living with cancer, a vulnerable population that has been underserved in the recent revolution in targeted therapeutics and immuno-oncology. The product candidate, DAY101, is an oral, brain-penetrant, highly-selective type II pan-rapidly accelerated fibrosarcoma, or pan-RAF, and kinase inhibitor.
About KRO Kronos Worldwide Inc
Kronos Worldwide Inc manufactures and sells titanium dioxide pigments. Titanium dioxide is a white inorganic pigment used in various products. The majority of Kronos' sales come from titanium dioxide used for coatings on automobiles, aircraft, machines, appliances, traffic paint, and in both commercial and residential interiors and exteriors. The second product category is titanium dioxide used for plastics such as packaging materials and food packaging, houseware, appliances, toys, and computer cases. The majority of revenue comes from the United States.